Inactive Instrument

Other languages Vilacto Bio Inc.

Equities

VIBI

US92686M1099

Other languages

Unlock all the news: Be the first to know and act before the market!

Vilacto Bio Inc. Reports Earnings Results for the First Quarter Ended June 30, 2019	20/19/20
Vilacto Bio Inc. Reports Earnings Results for the Full Year Ended March 31, 2019	10/19/10
Vilacto Bio Inc. Plans to Introduce 2 New Products	09/19/09
Vilacto Bio Offering Natural Alternatives to Strong Drugs in the Psoriasis and Diabetics Market	09/19/09
Vilacto Bio Inc. Informs its Patent Application for LACTOACTIVE to be Issued in Near Future	15/19/15
Vilacto Bio Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2018	20/19/20
Vilacto Bio Secured Patent Applications for Lactoactive®	30/18/30
Vilacto Bio Inc. Reports Earnings Results for the Second Quarter and Half Year Ended September 30, 2018	20/18/20
Vilacto Bio Inc. cancelled the acquisition of Pharma GP APS from 9 Heroes APS.	08/18/08
Vilacto Bio Inc. Announces Launch of Carmen Electra by Vilact®	01/18/01
Vilacto Bio Inc. announced that it expects to receive $0.17 million in funding from Auctus Private Equity Management, Inc.	26/18/26
Vilacto Bio Inc. announced that it expects to receive $0.13 million in funding from EMA Financial LLC	23/18/23
Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center	18/18/18
Vilacto Bio Inc. Retains The Equity Group Inc. to Facilitate All Aspects of Investor Relations and Financial Communications	17/17/17
Vilacto Bio Inc. in Final Stage of Developing Anti-Aging Products	10/17/10
Vilacto Bio Inc. Upgrades its Production Facility	14/17/14
Vilacto Bio Inc. entered into a stock purchase agreement to acquire Pharma GP APS from 9 Heroes APS for $6 million.	20/17/20
Zlato Inc. Announces Management Changes	03/17/03
Gert Andersen acquired 83.33% stake in Zlato Inc. from Dana Gallovicova for $0.13 million.	28/17/28
Vilacto Bio Inc. Auditor Raises 'Going Concern' Doubt	04/16/04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vilacto Bio Inc.

Equities

VIBI

US92686M1099

Other languages

Filters